MX9801515A - Preparado de combinacion para la aplicacion en la demencia. - Google Patents
Preparado de combinacion para la aplicacion en la demencia.Info
- Publication number
- MX9801515A MX9801515A MX9801515A MX9801515A MX9801515A MX 9801515 A MX9801515 A MX 9801515A MX 9801515 A MX9801515 A MX 9801515A MX 9801515 A MX9801515 A MX 9801515A MX 9801515 A MX9801515 A MX 9801515A
- Authority
- MX
- Mexico
- Prior art keywords
- insanity
- pharmaceutical preparation
- application
- combination pharmaceutical
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Un preparado de combinacion que contiene un compuesto que presenta un efecto inhibidor sobre la acetilcolinesterasa o un efecto muscarinogeno, y un compuesto que aumenta el nivel de endogeno extracelular de adenosina, se adecua para el tratamiento de la demencia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19707655.6 | 1997-02-26 | ||
| DE19707655A DE19707655A1 (de) | 1997-02-26 | 1997-02-26 | Kombinationspräparat zur Anwendung bei Demenz |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9801515A true MX9801515A (es) | 1998-08-30 |
| MXPA98001515A MXPA98001515A (es) | 1998-11-12 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| EP0608897A3 (en) | Tyrosine kinase inhibitors and benzoylacrylamide derivatives. | |
| ZA9810332B (en) | Aminothiazone inhibitors of cyclin dependent kinases. | |
| AU7696098A (en) | Substance p inhibitors in combination with nmda-blockers for treating pain | |
| AP2000001796A0 (en) | The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function | |
| HUP9801989A3 (en) | Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application | |
| GR3034289T3 (en) | Di- and trivalent small molecule selectin inhibitors | |
| CA2344407A1 (en) | Method for the treatment of mania and bipolar disorder | |
| AU7472798A (en) | Cox-2 inhibitors in combination with nmda-blockers for treating pain | |
| AU3107795A (en) | Inhibitors of the benzamidine type | |
| AU6617596A (en) | Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them | |
| ZA200007751B (en) | Transdermal therapeutic system containing hormones and chrystallization inhibitors. | |
| AU3611299A (en) | Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss | |
| DK0825857T3 (da) | Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse | |
| MXPA04004372A (es) | Derivados heterociclicos de glicinamida y su uso medico. | |
| ZA949151B (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents. | |
| AU2418499A (en) | Org-5222 in the treatment of depression | |
| EP0858262A4 (en) | THROMBIN INHIBITORS | |
| AU1031799A (en) | Sarcodictyin and eleutherobin useful for stabilising microtubules | |
| NZ320259A (en) | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors | |
| MX9801515A (es) | Preparado de combinacion para la aplicacion en la demencia. | |
| AP2000001728A0 (en) | Novel composition. | |
| ZA986273B (en) | Purine derivatives and the use for medicine thereof. | |
| ZA969586B (en) | The use of cholinesterase inhibitors in the treatment of xerostomia | |
| AU3737289A (en) | Agent for treating pancreatitis or the like |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |